Healthcare provider profile · identity verified

Pritee Gada, MD

Family Practice · TRUMBULL, CT · NPI 1093840092

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	322	94
Amlodipine Besylate	Amlodipine Besylate	175	65
Losartan Potassium	Losartan Potassium	168	53
Fluticasone Propionate	Fluticasone Propionate	135	76
Metoprolol Succinate	Metoprolol Succinate	133	38
Lisinopril	Lisinopril	129	41
Rosuvastatin Calcium	Rosuvastatin Calcium	120	41
Omeprazole	Omeprazole	108	33
Gabapentin	Gabapentin	103	36
Jardiance	Empagliflozin	102	29
Levothyroxine Sodium	Levothyroxine Sodium	91	27
Metformin Hcl	Metformin Hcl	83	21
Alprazolam	Alprazolam	77	24
Montelukast Sodium	Montelukast Sodium	75	23
Clopidogrel	Clopidogrel Bisulfate	74	13
Azithromycin	Azithromycin	72	67
Carvedilol	Carvedilol	69	15
Albuterol Sulfate Hfa	Albuterol Sulfate	67	23
Bupropion Xl	Bupropion Hcl	67	19
Trazodone Hcl	Trazodone Hcl	67	21
Pantoprazole Sodium	Pantoprazole Sodium	66	19
Januvia	Sitagliptin Phosphate	65	21
Metformin Hcl Er	Metformin Hcl	63	24
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	58	18
Tramadol Hcl	Tramadol Hcl	55	16
Triamcinolone Acetonide	Triamcinolone Acetonide	54	26
Tizanidine Hcl	Tizanidine Hcl	53	25
Alendronate Sodium	Alendronate Sodium	51	18
Cefuroxime	Cefuroxime Axetil	51	45
Pravastatin Sodium	Pravastatin Sodium	50	18
Eliquis	Apixaban	49	suppressed
Famotidine	Famotidine	48	19
Glipizide Er	Glipizide	43	16
Escitalopram Oxalate	Escitalopram Oxalate	42	16
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	40	27
Hydralazine Hcl	Hydralazine Hcl	39	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	39	suppressed
Meclizine Hcl	Meclizine Hcl	39	15
Simvastatin	Simvastatin	38	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	11
Tamsulosin Hcl	Tamsulosin Hcl	37	11
Furosemide	Furosemide	36	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	32	32
Trulicity	Dulaglutide	31	suppressed
Glimepiride	Glimepiride	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Clonazepam	Clonazepam	24	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	24	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Allopurinol	Allopurinol	17	suppressed
Ondansetron Odt	Ondansetron	17	14
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Potassium Chloride	Potassium Chloride	16	suppressed
Valsartan	Valsartan	16	suppressed
Baclofen	Baclofen	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	14
Amoxicillin	Amoxicillin	14	11
Duloxetine Hcl	Duloxetine Hcl	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Sertraline Hcl	Sertraline Hcl	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Colchicine	Colchicine	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Atenolol	Atenolol	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error